Digest Network Come funziona
Network
/
Società
In
Non verificato

InduPro, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaOncologiaSaluteScienza

4 comunicati stampa

Guarda tutti i comunicati
12/08/2026
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
InduPro Closes $77 Million Series B Financing and Doses First Patient in Phase 1 Study of Lead Oncology Program IDP-001
Fonte
InduPro, Inc.
Emittente
Business Wire
1.00
0
27/05/2026
InduPro Therapeutics Appoints Amanda J. Redig, MD, PhD, as Chief Medical Officer
Fonte
InduPro, Inc.
Emittente
Business Wire
1.00
0
07/01/2026
Oncologia
Salute
Scienza
Farmaceutica
Biotecnologia
InduPro Therapeutics Announces Strategic Collaboration with Lilly to Develop First-in-Class Bispecific/Multispecific Oncology Therapeutics Using InduPro’s Proximity-Guided Platform
Fonte
InduPro, Inc.
Emittente
Business Wire
1.00
0
10/12/2025
Mercato del lavoro
Oncologia
Salute
Scienza
Farmaceutica
Biotecnologia
InduPro Therapeutics Announces Strategic Investment from Sanofi and a Research Collaboration to Advance a Novel Bispecific for Autoimmune Disorders
Fonte
InduPro, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0